After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$110.79K

Rothblatt Martine A Chairperson & CEO

Transaction date Jun 15, 2026
Public filing date Jun 16, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$549.57 Jun 15, 2026
First close after public filing
$551.47 Jun 17, 2026
30-day return after filing
-4.07% Through Jul 16, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
205 shares @ $540.43
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000079
Filing cohort

Transactions in this filing

Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$6.6M
Buys / sales
0 / 13
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jun 15, 2026 $1.39M
United Therapeutics Corp UTHR Sale Jun 15, 2026 $40.41K
United Therapeutics Corp UTHR Current Sale Jun 15, 2026 $110.79K
United Therapeutics Corp UTHR Sale Jun 15, 2026 $108.32K
United Therapeutics Corp UTHR Sale Jun 15, 2026 $239.14K
United Therapeutics Corp UTHR Sale Jun 15, 2026 $441.32K
United Therapeutics Corp UTHR Sale Jun 15, 2026 $256.73K
United Therapeutics Corp UTHR Sale Jun 15, 2026 $263.96K
United Therapeutics Corp UTHR Sale Jun 15, 2026 $800.3K
United Therapeutics Corp UTHR Sale Jun 15, 2026 $402.28K
United Therapeutics Corp UTHR Sale Jun 15, 2026 $973.66K
United Therapeutics Corp UTHR Sale Jun 15, 2026 $650.85K
United Therapeutics Corp UTHR Sale Jun 15, 2026 $419.97K
United Therapeutics Corp UTHR Sale Jun 15, 2026 $509.2K
United Therapeutics Corp UTHR Exercise Jun 15, 2026 $0